Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20190307042954N1Phase 3Completed
Phase 3 trial of Chlordiazepoxide in anxiety disorder (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoint: Change in serum potassium levels. Started Jul 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20190307042954N1.